AU512027B2 - 6' desoxo derivatives of ergot peptide alkaloid - Google Patents

6' desoxo derivatives of ergot peptide alkaloid

Info

Publication number
AU512027B2
AU512027B2 AU28572/77A AU2857277A AU512027B2 AU 512027 B2 AU512027 B2 AU 512027B2 AU 28572/77 A AU28572/77 A AU 28572/77A AU 2857277 A AU2857277 A AU 2857277A AU 512027 B2 AU512027 B2 AU 512027B2
Authority
AU
Australia
Prior art keywords
ergot peptide
peptide alkaloid
desoxo
derivatives
desoxo derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU28572/77A
Other versions
AU2857277A (en
Inventor
P. and Stadler P Stutz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1128676A external-priority patent/CH623591A5/en
Priority claimed from CH1128776A external-priority patent/CH623592A5/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU2857277A publication Critical patent/AU2857277A/en
Application granted granted Critical
Publication of AU512027B2 publication Critical patent/AU512027B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU28572/77A 1976-09-06 1977-09-06 6' desoxo derivatives of ergot peptide alkaloid Expired AU512027B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1128676A CH623591A5 (en) 1976-09-06 1976-09-06 Process for the preparation of ergopeptide alkaloid derivatives
CHCH11,287/7 1976-09-06
CHCH11,286/7 1976-09-06
CH1128776A CH623592A5 (en) 1976-09-06 1976-09-06 Process for the preparation of ergopeptide alkaloid derivatives

Publications (2)

Publication Number Publication Date
AU2857277A AU2857277A (en) 1979-03-15
AU512027B2 true AU512027B2 (en) 1980-09-18

Family

ID=25708069

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28572/77A Expired AU512027B2 (en) 1976-09-06 1977-09-06 6' desoxo derivatives of ergot peptide alkaloid

Country Status (15)

Country Link
JP (1) JPS5331698A (en)
AU (1) AU512027B2 (en)
CA (1) CA1105007A (en)
DE (1) DE2738730A1 (en)
DK (1) DK147390C (en)
ES (1) ES462080A1 (en)
FI (1) FI64942C (en)
FR (1) FR2363571A1 (en)
GB (2) GB1590150A (en)
IE (1) IE46152B1 (en)
IL (1) IL52896A (en)
NL (1) NL7709683A (en)
NZ (1) NZ185098A (en)
PT (1) PT67003B (en)
SE (1) SE435839B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8604035B2 (en) * 2011-06-23 2013-12-10 Map Pharmaceuticals, Inc. Fluoroergoline analogs

Also Published As

Publication number Publication date
IL52896A0 (en) 1977-11-30
DK147390C (en) 1985-02-04
FR2363571A1 (en) 1978-03-31
JPS5331698A (en) 1978-03-25
GB1590149A (en) 1981-05-28
GB1590150A (en) 1981-05-28
NL7709683A (en) 1978-03-08
CA1105007A (en) 1981-07-14
PT67003B (en) 1979-05-14
AU2857277A (en) 1979-03-15
IE46152L (en) 1978-03-06
DK147390B (en) 1984-07-16
FI772557A (en) 1978-03-07
SE7709645L (en) 1978-03-07
ES462080A1 (en) 1978-12-01
DK382777A (en) 1978-03-07
IL52896A (en) 1980-07-31
IE46152B1 (en) 1983-03-09
FI64942C (en) 1984-02-10
FI64942B (en) 1983-10-31
DE2738730A1 (en) 1978-03-16
PT67003A (en) 1977-10-01
NZ185098A (en) 1980-04-28
FR2363571B1 (en) 1980-04-18
SE435839B (en) 1984-10-22

Similar Documents

Publication Publication Date Title
AU520754B2 (en) Nasal ergot alkaloid compositions
AU536181B2 (en) Derivatives of camptothecin
AU519643B2 (en) Derivatives of morphine
JPS532417A (en) Derivatives of dipeptide
JPS52156811A (en) Derivatives of dipeptide
AU514744B2 (en) Derivatives of vincamine and arovincamine
AU540977B2 (en) Preparation of vincamine derivatives
AU512158B2 (en) Preparation of vincamine
AU500908B2 (en) Preparation of quinazoline derivatives
AU514324B2 (en) Preparation of alkaloids ofthe leurosine type
AU511055B2 (en) Amide derivatives of'VLB, Leuosidine, Leuocristine and related dimeric alkaloids
AU506573B2 (en) 3'phenoxybenzyl-l-phenyl-cyclobutane-l-carboxylate derivatives
JPS5371100A (en) Oxazolidinedion derivative of nichinichi alkaloid
AU512027B2 (en) 6' desoxo derivatives of ergot peptide alkaloid
PH16894A (en) Preparation of rifamycin q derivatives
GB2121030B (en) Ergot peptide derivatives
AU525818B2 (en) Ergot peptide alkaloid derivates
AU513821B2 (en) Ergoline derivatives
AU512322B2 (en) Derivatives of 2-phenyl-2-hydroxyethylamine
GR59327B (en) Preparation process of alkaloid derivatives
AU518954B2 (en) Derivatives of 9-chloroprednisolone
AU2103877A (en) Ergot alkaloid derivatives
IL52632A0 (en) Novel alkaloid derivatives and their preparation
AU3116077A (en) 6-substituted derivatives of d 8-ergolin-1-ylacetamide
AU6533580A (en) Derivatives of cyclic peptide nuclei